{"status":"ok","message-type":"event-list","message":{"next-cursor":"d3683087-1748-2e13-18bb-e96caf3b9441","total-results":1,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1054\/mehy.1999.0848","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-12-01T00:00:00Z","subj_id":"https:\/\/lens.org\/099-844-391-682-063","id":"d3683087-1748-2e13-18bb-e96caf3b9441","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-Cd160 Specific Antibodies For The Treatment Of Eye Disorders Based On Neoangiogenesis","pid":"https:\/\/lens.org\/099-844-391-682-063","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-12T00:34:52Z","relation_type_id":"cites"}]}}